Association study between the neurexin‐1 gene and tardive dyskinesia

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Human psychopharmacology

• Publication date

  2017-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/hup.2568PMID 28120489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association study between the neurexin‐1 gene and tardive dyskinesia

  2017cited by this paper
• Identification of Candidate Single-Nucleotide Polymorphisms in NRXN1 Related to Antipsychotic Treatment Response in Patients with Schizophrenia

  2014cited by this paper
• Incomplete penetrance of NRXN1 deletions in families with schizophrenia.

  2014cited by this paper
• Gaba transporter SLC6A11 gene polymorphism associated with tardive dyskinesia

  2014cited by this paper
• The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue

  2014cited by this paper
• Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia.

  2013cited by this paper
• The pharmacogenetics of antipsychotic-induced adverse events

  2013cited by this paper
• Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature

  2013cited by this paper
• Copy number variations in neurodevelopmental disorders.

  2012cited by this paper
• Phenotypic spectrum and genotype–phenotype correlations of NRXN1 exon deletions

  2012cited by this paper
• The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.

  2011cited by this paper
• Neurexin-1 and Frontal Lobe White Matter: An Overlapping Intermediate Phenotype for Schizophrenia and Autism Spectrum Disorders

  2011cited by this paper
• Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response

  2010cited by this paper
• Deletions of NRXN1 (Neurexin-1) Predispose to a Wide Spectrum of Developmental Disorders

  2010cited by this paper
• Neurexins physically and functionally interact with GABA(A) receptors.

  2010cited by this paper
• Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia.

  2009cited by this paper
• Neurexin 1 (NRXN1) deletions in schizophrenia.

  2009cited by this paper
• Disruption of the neurexin 1 gene is associated with schizophrenia.

  2009cited by this paper
• Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology.

  2008cited by this paper
• Pathway-based association analysis of genome-wide screening data suggest that genes associated with the &ggr;-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia

  2008cited by this paper
• Addictions biology: haplotype-based analysis for 130 candidate genes on a single array.

  2008cited by this paper
• Likelihood-Based Association Analysis for Nuclear Families and Unrelated Subjects with Missing Genotype Data

  2008influential reference
• Mutational analysis of the neurexin/neuroligin complex reveals essential and regulatory components

  2008cited by this paper
• Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology

  2008cited by this paper
• The neuroligin and neurexin families: from structure to function at the synapse

  2006cited by this paper
• QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies

  2006influential reference
• A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins.

  2005cited by this paper
• A Splice Code for trans-Synaptic Cell Adhesion Mediated by Binding of Neuroligin 1 to α- and β-Neurexins

  2005cited by this paper
• Haploview: analysis and visualization of LD and haplotype maps

  2005cited by this paper
• Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins.

  2004cited by this paper
• Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

  2000cited by this paper
• Familial occurrence of tardive dyskinesia.

  1998cited by this paper
• Binding Properties of Neuroligin 1 and Neurexin 1β Reveal Function as Heterophilic Cell Adhesion Molecules*

  1997cited by this paper
• Tardive dyskinesia: behavioral effects of repeated intracerebroventricular haloperidol injections in rats do not confirm the kindling hypothesis.

  1994cited by this paper
• A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies.

  1991cited by this paper
• Familial psychosis and vulnerability to tardive dyskinesia.

  1989cited by this paper
• Research diagnoses for tardive dyskinesia.

  1982cited by this paper
• Familial tardive dyskinesia.

  1981cited by this paper
• Familial occurrence of tardive dyskinesia.

  1981cited by this paper
• The pathophysiologic basis of tardive dyskinesia.

  1977cited by this paper

• Putative role of immune reactions in the mechanism of tardive dyskinesia

  2023cites this paper
• Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies

  2022cites this paper
• Copy number variant syndromes are frequent in schizophrenia: progressing towards a CNV-schizophrenia model

  2019cites this paper
• Genotype Variations of rs13381800 in TCF4 Gene and rs17039988 in NRXN1 Gene among a Sample of Iranian Patients with Schizophrenia

  2019cites this paper
• Investigation of the HSPG2 Gene in Tardive Dyskinesia – New Data and Meta-Analysis

  2018cites this paper
• Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications

  2018cites this paper
• Association study between the neurexin‐1 gene and tardive dyskinesia

  2017cites this paper